GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 90 filers reported holding GENMARK DIAGNOSTICS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $1,298,000 | +72.6% | 183,051 | +18.4% | 0.00% | 0.0% |
| Q4 2018 | $752,000 | -67.2% | 154,651 | -50.4% | 0.00% | 0.0% |
| Q3 2018 | $2,290,000 | +121.7% | 311,680 | +92.5% | 0.00% | 0.0% |
| Q2 2018 | $1,033,000 | +13.5% | 161,948 | -3.1% | 0.00% | 0.0% |
| Q1 2018 | $910,000 | +24.3% | 167,204 | -4.8% | 0.00% | – |
| Q4 2017 | $732,000 | -55.5% | 175,560 | +2.8% | 0.00% | -100.0% |
| Q3 2017 | $1,644,000 | -17.7% | 170,731 | +1.1% | 0.00% | 0.0% |
| Q2 2017 | $1,998,000 | -7.0% | 168,888 | +0.8% | 0.00% | -50.0% |
| Q1 2017 | $2,149,000 | +0.0% | 167,620 | -4.5% | 0.00% | 0.0% |
| Q4 2016 | $2,148,000 | +4.9% | 175,516 | +1.2% | 0.00% | +100.0% |
| Q3 2016 | $2,047,000 | +40.9% | 173,435 | +3.8% | 0.00% | 0.0% |
| Q2 2016 | $1,453,000 | +60.4% | 167,060 | -2.8% | 0.00% | 0.0% |
| Q1 2016 | $906,000 | -34.2% | 171,827 | -3.1% | 0.00% | 0.0% |
| Q4 2015 | $1,377,000 | -4.8% | 177,399 | -3.5% | 0.00% | 0.0% |
| Q3 2015 | $1,446,000 | +8.6% | 183,753 | +25.1% | 0.00% | 0.0% |
| Q2 2015 | $1,331,000 | -29.9% | 146,858 | +0.3% | 0.00% | 0.0% |
| Q1 2015 | $1,900,000 | -4.6% | 146,383 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $1,992,000 | +41.8% | 146,383 | -6.6% | 0.00% | 0.0% |
| Q3 2014 | $1,405,000 | -34.3% | 156,658 | -0.9% | 0.00% | 0.0% |
| Q2 2014 | $2,138,000 | +56.3% | 158,020 | +14.8% | 0.00% | 0.0% |
| Q1 2014 | $1,368,000 | -26.8% | 137,635 | -2.0% | 0.00% | 0.0% |
| Q4 2013 | $1,870,000 | +13.7% | 140,515 | +3.8% | 0.00% | 0.0% |
| Q3 2013 | $1,644,000 | +33.8% | 135,345 | +13.9% | 0.00% | 0.0% |
| Q2 2013 | $1,229,000 | – | 118,835 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|